Left Atrial Appendage Closure for Atrial Fibrillation in the Elderly >75 Years Old: A Meta-Analysis of Observational

Shaojie Han1, Ruikun Jia1, Shenyu Zhao1

  • 1Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.

Insights

Elderly patients (≥75 years) undergoing left atrial appendage closure (LAAC) face higher risks of procedural complications like mortality and bleeding. However, long-term stroke/TIA rates remain similar to younger patients after LAAC.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Medicine

Background:

  • Left atrial appendage closure (LAAC) is a key therapy for atrial fibrillation (AF).
  • Limited data exists on LAAC safety and efficacy in elderly patients (≥75 years).
  • This meta-analysis compares procedural complications and long-term outcomes in elderly versus non-elderly patients undergoing LAAC.

Purpose of the Study:

  • To investigate procedural complications and long-term outcomes of LAAC in elderly patients compared to non-elderly patients.
  • To assess differences in successful implantation rates, periprocedural events, and long-term adverse events.

Main Methods:

  • A comprehensive meta-analysis of studies from PubMed, EMBASE, Cochrane Library, and Web of Science.
  • Inclusion of 12 studies with 25,094 elderly and 36,035 non-elderly patients.
  • Analysis of procedural endpoints (e.g., mortality, bleeding, effusion, stroke, access complications) and long-term outcomes (mortality, bleeding, stroke/TIA).

Main Results:

  • Successful LAAC implantation rates were similar between elderly and non-elderly groups.
  • Elderly patients showed significantly higher rates of periprocedural mortality, pericardial effusion/tamponade, major bleeding, and vascular access complications.
  • Long-term stroke/transient ischemic attack (TIA) rates were comparable between the groups at one-year follow-up.

Conclusions:

  • While LAAC implantation success is comparable, elderly patients experience increased periprocedural risks.
  • Higher incidences of mortality, bleeding, access complications, and pericardial effusion/tamponade are noted in the elderly.
  • LAAC remains a viable option for elderly AF patients, with similar long-term stroke/TIA risk as younger counterparts.